CAS RN: 155-58-8
Rhaponticin
Product Availability
Choose a grade to view its available package options.
6 package records5 with current stock4 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260119 |
1ml |
In stock |
| | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260224 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20251208 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250502 |
50mg |
In stock |
Shanghai | | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250806 |
5mg / 20mg / 100mg / 500mg |
Confirm by inquiry |
Shanghai, Shandong, Hebei | | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250914 |
20mg |
Out of stock |
| 8-10 business days | Inquiry |
-
Product code:
ICTR0252
-
Purity/Analytical Methods:
>98.0%(HPLC)
GET A QUOTE
155-58-8 / (2S,3R,4S,5S,6R)-2-[3-hydroxy-5-[(E)-2-(3-hydroxy-4-methoxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Standard CAS: 155-58-8
Multi CAS: No
Basic Information
CAS
155-58-8
Multi CAS
No
Molecular Formula
C21H24O9
Molecular Weight
420.400000
Exact Mass
420.142032
SMILES
COC1=C(C=C(C=C1)/C=C/C2=CC(=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O
InChI
InChI=1S/C21H24O9/c1-28-16-5-4-11(8-15(16)24)2-3-12-6-13(23)9-14(7-12)29-21-20(27)19(26)18(25)17(10-22)30-21/h2-9,17-27H,10H2,1H3/b3-2+/t17-,18-,19+,20-,21-/m1/s1
InChIKey
GKAJCVFOJGXVIA-DXKBKAGUSA-N
Computed Properties
Structural Parameters
Heavy atom count
30
Aromatic heavy atom count
12
Fraction Csp3
0.33
Rotatable bonds
6
H-bond acceptors
9
H-bond donors
6
Molar refractivity
106.09
TPSA
149.07
LogP / Solubility
WLOGP
0.46
MLOGP
0.43
XLogP3
0.5
Consensus LogP
0.46
Log S (ESOL)
-2.63
Class (ESOL)
Moderately soluble
Log S (Ali)
-3.34
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.49
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.96
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5